Connor, Clark & Lunn Investment Management Ltd. Maravai Lifesciences Holdings, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 390,267 shares of MRVI stock, worth $2.32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
390,267
Previous 450,462
13.36%
Holding current value
$2.32 Million
Previous $3.23 Million
0.56%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding MRVI
# of Institutions
233Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$120 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$83.4 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$70.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$57.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$49.7 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $783M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...